Related Experiment Video
Updated: Jan 4, 2026

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Neuropeptide Y in itch regulation
Jon E T Jakobsson1, Haisha Ma1, Malin C Lagerström1
1Department of Neuroscience, Uppsala University, 751 24 Uppsala, Sweden.
Itch signals activate spinal neurons via neurotransmitters like somatostatin. Neuropeptide Y (NPY) and somatostatin receptors partly regulate the same itch pathways, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Dermatology
- Pharmacology
Background:
- Itch is a critical sensory signal for detecting threats.
- Pruritogenic substances activate skin neurons, transmitting signals to the spinal cord.
- Spinal interneurons utilize neurotransmitters like somatostatin and natriuretic polypeptide b to process itch signals.
Purpose of the Study:
- To review recent findings on the role of Neuropeptide Y (NPY)/Y1 and somatostatin/SST2A receptors in itch.
- To integrate the understanding of NPY and somatostatin signaling in itch pathways.
- To explore potential therapeutic targets for itch modulation.
Main Methods:
- Literature review of recent research on NPY/Y1 and somatostatin/SST2A receptors in itch.
- Analysis of studies investigating neurotransmitter interactions in the spinal cord's itch circuitry.
- Integration of data on somatostatin-expressing interneurons co-expressing NPY Y1 receptors.
Main Results:
- A significant sub-population of somatostatin-expressing spinal interneurons also express the NPY Y1 receptor.
- NPY and somatostatin partially regulate the same neuronal pathways involved in itch transmission.
- Evidence suggests a convergence of NPY and somatostatin signaling in the central processing of itch.
Conclusions:
- The NPY/Y1 and somatostatin/SST2A receptor systems play crucial roles in modulating itch sensation.
- The co-expression of NPY Y1 receptors on somatostatin interneurons highlights a key interaction point.
- Targeting these neurotransmitter systems offers promising avenues for novel anti-itch therapies.
More Related Videos
08:01Cutaneous Surgical Denervation: A Method for Testing the Requirement for Nerves in Mouse Models of Skin Disease
Published on: June 26, 2016
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Related Concept Videos
Regulation of Food Intake
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Nociception
Local Anesthetics: Differential Sensitivity of Nerve Fibers